211 related articles for article (PubMed ID: 16822902)
1. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.
Bhojwani D; Kang H; Moskowitz NP; Min DJ; Lee H; Potter JW; Davidson G; Willman CL; Borowitz MJ; Belitskaya-Levy I; Hunger SP; Raetz EA; Carroll WL
Blood; 2006 Jul; 108(2):711-7. PubMed ID: 16822902
[TBL] [Abstract][Full Text] [Related]
2. Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia.
Kirschner-Schwabe R; Lottaz C; Tödling J; Rhein P; Karawajew L; Eckert C; von Stackelberg A; Ungethüm U; Kostka D; Kulozik AE; Ludwig WD; Henze G; Spang R; Hagemeier C; Seeger K
Clin Cancer Res; 2006 Aug; 12(15):4553-61. PubMed ID: 16899601
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype.
Staal FJ; de Ridder D; Szczepanski T; Schonewille T; van der Linden EC; van Wering ER; van der Velden VH; van Dongen JJ
Leukemia; 2010 Mar; 24(3):491-9. PubMed ID: 20072147
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide excision repair is a predictor of early relapse in pediatric acute lymphoblastic leukemia.
Ibrahim OM; As Sobeai HM; Grant SG; Latimer JJ
BMC Med Genomics; 2018 Oct; 11(1):95. PubMed ID: 30376844
[TBL] [Abstract][Full Text] [Related]
5. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
Konrad M; Metzler M; Panzer S; Ostreicher I; Peham M; Repp R; Haas OA; Gadner H; Panzer-Grumayer ER
Blood; 2003 May; 101(9):3635-40. PubMed ID: 12506024
[TBL] [Abstract][Full Text] [Related]
6. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
[TBL] [Abstract][Full Text] [Related]
7. Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.
Davidsson J; Paulsson K; Lindgren D; Lilljebjörn H; Chaplin T; Forestier E; Andersen MK; Nordgren A; Rosenquist R; Fioretos T; Young BD; Johansson B
Leukemia; 2010 May; 24(5):924-31. PubMed ID: 20237506
[TBL] [Abstract][Full Text] [Related]
8. Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.
Szczepanek J; Styczyński J; Haus O; Tretyn A; Wysocki M
Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):61-8. PubMed ID: 21246408
[TBL] [Abstract][Full Text] [Related]
9. Attenuating the abnormally high expression of AEBP1 suppresses the pathogenesis of childhood acute lymphoblastic leukemia via p53-dependent signaling pathway.
Li S; Juan CX; Feng AM; Bian HL; Liu WD; Zhang GQ; Wang CZ; Cao Q; Zhou GP
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1184-1195. PubMed ID: 30779088
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia.
Bárcenas-López DA; Núñez-Enríquez JC; Hidalgo-Miranda A; Beltrán-Anaya FO; May-Hau DI; Jiménez-Hernández E; Bekker-Méndez VC; Flores-Lujano J; Medina-Sansón A; Tamez-Gómez EL; López-García VH; Lara-Ramos JR; Núñez-Villegas NN; Peñaloza-González JG; Flores-Villegas LV; Amador-Sánchez R; Espinosa-Elizondo RM; Martín-Trejo JA; Velázquez-Aviña MM; Merino-Pasaye LE; Pérez-Saldívar ML; Duarte-Rodríguez DA; Torres-Nava JR; Cortés-Herrera B; Solís-Labastida KA; González-Ávila AI; Santillán-Juárez JD; García-Velázquez AJ; Rosas-Vargas H; Mata-Rocha M; Sepúlveda-Robles OA; Mejía-Aranguré JM; Jiménez-Morales S
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183133
[TBL] [Abstract][Full Text] [Related]
11. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia
Saliba J; Evensen NA; Meyer JA; Newman D; Nersting J; Narang S; Ma X; Schmiegelow K; Carroll WL
Pediatr Blood Cancer; 2020 Jul; 67(7):e28306. PubMed ID: 32391957
[TBL] [Abstract][Full Text] [Related]
13. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse.
Núñez-Enríquez JC; Bárcenas-López DA; Hidalgo-Miranda A; Jiménez-Hernández E; Bekker-Méndez VC; Flores-Lujano J; Solis-Labastida KA; Martínez-Morales GB; Sánchez-Muñoz F; Espinoza-Hernández LE; Velázquez-Aviña MM; Merino-Pasaye LE; García Velázquez AJ; Pérez-Saldívar ML; Mojica-Espinoza R; Ramírez-Bello J; Jiménez-Morales S; Mejía-Aranguré JM;
Arch Med Res; 2016 Nov; 47(8):644-655. PubMed ID: 28476192
[TBL] [Abstract][Full Text] [Related]
15. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone.
Choi S; Henderson MJ; Kwan E; Beesley AH; Sutton R; Bahar AY; Giles J; Venn NC; Pozza LD; Baker DL; Marshall GM; Kees UR; Haber M; Norris MD
Blood; 2007 Jul; 110(2):632-9. PubMed ID: 17371950
[TBL] [Abstract][Full Text] [Related]
16. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].
Bhojwani D; Kang H; Menezes RX; Yang W; Sather H; Moskowitz NP; Min DJ; Potter JW; Harvey R; Hunger SP; Seibel N; Raetz EA; Pieters R; Horstmann MA; Relling MV; den Boer ML; Willman CL; Carroll WL; ; ;
J Clin Oncol; 2008 Sep; 26(27):4376-84. PubMed ID: 18802149
[TBL] [Abstract][Full Text] [Related]
17. Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia.
Irving JA
Br J Haematol; 2016 Mar; 172(5):655-66. PubMed ID: 26568036
[TBL] [Abstract][Full Text] [Related]
18. Mutational profiling of acute lymphoblastic leukemia with testicular relapse.
Ding LW; Sun QY; Mayakonda A; Tan KT; Chien W; Lin DC; Jiang YY; Xu L; Garg M; Lao ZT; Lill M; Yang H; Yeoh AE; Koeffler HP
J Hematol Oncol; 2017 Mar; 10(1):65. PubMed ID: 28253933
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
20. Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection.
Li A; Zhou J; Zuckerman D; Rue M; Dalton V; Lyons C; Silverman LB; Sallan SE; Gribben JG
Blood; 2003 Dec; 102(13):4520-6. PubMed ID: 12946997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
